EyePoint Names Tarek S. Hassan, MD, as SVP and Chief Strategic Science Officer
Tarek S. Hassan, MD.WATERTOWN, Mass.—EyePoint, Inc. (Nasdaq: EYPT), a clinical-stage biopharmaceutical company and developer of therapeutics for patients with serious retinal diseases, has announced the appointment of Tarek…
